Variability in drug metabolizing enzyme activity in HIV-infected patients.
about
PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2Recognition and management of significant drug interactions in HIV patients: challenges in using available data to guide therapyIncreased exposure of norethindrone in HIV+ women treated with ritonavir-boosted atazanavir therapy.Addressing phenoconversion: the Achilles' heel of personalized medicine.Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients.Detection of an endogenous urinary biomarker associated with CYP2D6 activity using global metabolomicsSelective modulation of hepatic cytochrome P450 and flavin monooxygenase 3 expression during citrobacter rodentium infection in severe combined immune-deficient mice.Role of oxidative stress in infectious diseases. A review.Inflammation and pharmacokinetics: potential implications for HIV-infection.Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation.Regulation of drug-metabolizing enzymes in infectious and inflammatory disease: implications for biologics-small molecule drug interactions.Characterization of the genetic profile of CYP2C19 in two South African populations.Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach.Endotoxin-Mediated Downregulation of Hepatic Drug Transporters in HIV-1 Transgenic Rats.Safety and pharmacokinetics of the CIME combination of drugs and their metabolites after a single oral dosing in healthy volunteers.Influence of chronic hepatitis C infection on cytochrome P450 3A4 activity using midazolam as an in vivo probe substrate.Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s.Whole-genome resequencing in pharmacogenomics: moving away from past disparities to globally representative applications.Inflammation and Organ Failure Severely Affect Midazolam Clearance in Critically Ill Children.Effects of Seijo-bofu-to, a traditional Japanese herbal medicine containing furanocoumarin derivatives, on the drug-metabolizing enzyme activities in healthy male volunteers.A herbal-drug interaction study of keishi-bukuryo-gan, a traditional herbal preparation used for menopausal symptoms, in healthy female volunteers.CYP450 genotype and pharmacogenetic association studies: a critical appraisalEvaluation of predictiveCYP2C19genotyping assays relative to measured phenotype in a South African cohort
P2860
Q27011622-DAB88866-07FC-4023-B518-25288DBDBDF4Q33644204-6BC05085-75CF-4288-AAE2-6A47AD5FDEEDQ34718314-C2EBFC2D-0752-4805-937D-50AE1486FC1DQ35023701-24AFE93F-EC29-427A-A34D-7337D8CDBDD7Q35120591-7991443B-1E71-4DAF-B7AF-1B7092AE3D20Q35800807-15AB37E4-1D00-4D31-A8A7-16B7240B24AAQ36296195-57C94B63-1109-4EE8-939C-1135B061987EQ38090568-54AA3319-F8C7-41EE-9226-3D8527511C98Q38740792-AD5790C4-3BFD-456C-9AF3-FA1CE739CB87Q38803026-651157E9-D1DD-4493-8DB6-E417A5D02351Q39325953-41E1308B-F634-4A2D-A705-F0E1B8182051Q39667176-B6E391A8-B293-4898-A48A-E8DA6D9B80D8Q40717885-54DA226E-BC69-48BA-B479-8609E8B46B07Q40755393-3FCBD0DB-C30A-4833-9129-8FF1EE1CD549Q41737190-2C82658A-A0EA-4345-831A-400D666A167EQ42993169-CBB45FF7-232F-42C0-8EFD-9184CB6AE095Q46016007-0B47D8C2-6287-4F94-B084-7CF94F2F37A4Q46831924-C600E39D-1031-4055-95D7-1CBAB51E575EQ47600302-8ABCB841-DA79-4133-8FBC-75DA2DB30589Q47664139-EE9366CF-5191-4421-9B8D-8C28A6652C91Q51348862-0D56E273-FE1F-45BC-BFD1-6FC9C7FBEFFCQ57585515-99F65215-D226-4DEE-BF19-A507F00ECCEBQ59205492-49A53AEE-F63E-4B83-BD29-B31E351B34C9
P2860
Variability in drug metabolizing enzyme activity in HIV-infected patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Variability in drug metabolizing enzyme activity in HIV-infected patients.
@ast
Variability in drug metabolizing enzyme activity in HIV-infected patients.
@en
type
label
Variability in drug metabolizing enzyme activity in HIV-infected patients.
@ast
Variability in drug metabolizing enzyme activity in HIV-infected patients.
@en
prefLabel
Variability in drug metabolizing enzyme activity in HIV-infected patients.
@ast
Variability in drug metabolizing enzyme activity in HIV-infected patients.
@en
P2093
P2860
P1476
Variability in drug metabolizing enzyme activity in HIV-infected patients.
@en
P2093
Amanda E Jones
Andrea Gaedigk
Angela D M Kashuba
Karl Gotzkowsky
Kevin C Brown
Mike Blake
Rebecca E Werner
P2860
P2888
P304
P356
10.1007/S00228-009-0777-6
P577
2010-01-19T00:00:00Z
P5875
P6179
1031033607